Approvals/TGA/WEGOVY 1.7 mg semaglutide 2.27 mg/mL solution for injection pre-filled pen with pre-assembled needle

Approved

STANDARD

WEGOVY 1.7 mg semaglutide 2.27 mg/mL solution for injection pre-filled pen with pre-assembled needle

Novo Nordisk Pharmaceuticals Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 170ff8cd54184948
Product Name: WEGOVY 1.7 mg semaglutide 2.27 mg/mL solution for injection pre-filled pen with pre-assembled needle
Artg Id: 356287
Artg Name: WEGOVY 1.7 mg semaglutide 2.27 mg/mL solution for injection pre-filled pen with pre-assembled needle
Sponsor: Novo Nordisk Pharmaceuticals Pty Ltd
Company Detail Path: /organization/novo-nordisk-pharmaceuticals-pty-limited
Artg Date: 2022-09-01
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Product Information: https://medical-cdn.nocode.com/drug_tga/9e74cf183c2600a39df2c3adc71a2239.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

170ff8cd54184948

Type

Standard